US20100261745A1 - Pharmaceutical formulation - Google Patents

Pharmaceutical formulation Download PDF

Info

Publication number
US20100261745A1
US20100261745A1 US12/639,889 US63988909A US2010261745A1 US 20100261745 A1 US20100261745 A1 US 20100261745A1 US 63988909 A US63988909 A US 63988909A US 2010261745 A1 US2010261745 A1 US 2010261745A1
Authority
US
United States
Prior art keywords
methylnaltrexone
solution
agent
ph
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/639,889
Inventor
Suketu P. Sanghvi
Thomas A. Boyd
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Progenics Pharmaceuticals Inc
Original Assignee
Progenics Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to US46161103P priority Critical
Priority to US10/821,811 priority patent/US20040266806A1/en
Application filed by Progenics Pharmaceuticals Inc filed Critical Progenics Pharmaceuticals Inc
Priority to US12/639,889 priority patent/US20100261745A1/en
Publication of US20100261745A1 publication Critical patent/US20100261745A1/en
Assigned to PROGENICS PHARMACEUTICALS, INC. reassignment PROGENICS PHARMACEUTICALS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SANGHVI, SUKETU P, BOYD, THOMAS A
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33299842&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20100261745(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application status is Abandoned legal-status Critical

Links